Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,729 evidence items · page 45 / 70

500 cells/mLLikelihood of retention reduced with CD4 ≥500 cells/mL.

NigeriaVIH/sidapublished 2020Journal of the International Association of Providers of AIDS CarePubMeddocument of 6 observations

2.54 odds_ratioAmong HIV-positive individuals, APOL1 polymorphisms in the recessive model were associated with increased risk of prevalent chronic kidney disease, with an adjusted odds ratio of 2.54.

Nigeriamaladie rénale chronique · VIH/sidapublished 2020American journal of kidney diseases : the official journal of the National Kidney FoundatiPubMeddocument of 7 observations

17.2 %Among HIV-infected women attending a tertiary health facility in Kano, Nigeria, 17.2% ever used timed unprotected intercourse without pre-exposure prophylaxis (PrEP) as a safer conception method.

NigeriaVIH/sidapublished 2019International journal of health policy and managementPubMeddocument of 10 observations

0.79 aORAdolescents and young adults in the 'consent and proximity' class were less likely to report condom use (adjusted odds ratio 0.79, 95% confidence interval 0.63–0.99).

NigeriaVIH/sidaobserved 2018published 2024PloS onePubMeddocument of 15 observations

4.1 timesThe likelihood of HIV-negative pregnant women at term repeating an HIV test was approximately 4.1 times higher when referred by TBAs in cluster 1 compared to those in the control group.

NigeriaVIH/sidapublished 2024BMC pregnancy and childbirthPubMeddocument of 8 observations

30 %Retention-in-care rates among 5107 women ranged from 30% to 76% in the complete dataset.

NigeriaVIH/sidaobserved 2013–2017published 2020Journal of the International AIDS SocietyPubMeddocument of 3 observations

1.677 AORParticipants who were virally suppressed had a higher likelihood of favorable TB treatment outcome compared to those who were virally unsuppressed (adjusted odds ratio = 1.677, 95% confidence interval = 1.036–2.716).

Nigeriatuberculose · VIH/sidapublished 2024The Pan African medical journalPubMeddocument of 5 observations

0.5 %In 2019, the HIV positivity rate among screened pregnant women in Nigeria was 0.5%.

NigeriaVIH/sidaobserved 2019published 2021International journal of STD & AIDSPubMeddocument of 10 observations

1,900,000 peopleNigeria is home to approximately 1.9 million people living with HIV (PLHIV).

NigeriaVIH/sidapublished 2025PloS onePubMed

25.7 %Among 346 participants with complete data, 25.7% showed virological failure with preserved immunity.

NigeriaVIH/sidaobserved 2019–2021published 2026Frontiers in public healthPubMeddocument of 7 observations

14.4 score_on_4_to_20_scaleThe overall mean score on the HRQOL level of independence domain was 14.4 on a scale of 4–20.

NigeriaVIH/sidapublished 2020BMC public healthPubMeddocument of 11 observations

27 %Twenty-seven percent of participants were people with HIV.

NigeriaVIH/sidapublished 2024Journal of the International AIDS SocietyPubMeddocument of 9 observations

96 %Viral load testing uptake for HIV improved from 96% to 99% post-transition.

NigeriaVIH/sidapublished 2025BMC health services researchPubMeddocument of 9 observations

-0.1 Z-scoreThe mean BMI Z-score of age-matched HIV-negative controls was -0.10 ± 0.86.

NigeriaVIH/sidapublished 2022BMC pediatricsPubMeddocument of 6 observations

90.5 %The Problem List had sensitivity range 90.5%–85.7% and specificity range 68.3%–65.2% for detecting distress, anxiety, and depression in ART-naïve HIV infected patients, as measured by HADS.

NigeriaVIH/sidapublished 2019African health sciencesPubMeddocument of 2 observations

33.8 %33.8% of patients with HIV had intestinal parasites co-infections.

Nigeriaintestinal parasites · VIH/sidapublished 2011Acta tropicaeurope_pmcdocument of 5 observations

97 %The probability of partners of married respondents being aware of their spouse's HIV serostatus was 97%.

NigeriaVIH/sidapublished 2022Journal of biosocial sciencePubMeddocument of 8 observations

30 fold_increaseThe risk of psychological distress increased 30-fold in the first year on therapy in people with HIV in Nigeria.

NigeriaVIH/sidaobserved first yearpublished 2023International journal of behavioral medicinePubMeddocument of 7 observations

61 %Among 1,598 people living with HIV (PLHIV) on antiretroviral therapy (ART) in three states in southern Nigeria surveyed between July and August 2019, 61.0% were willing to pay for viral load testing services.

NigeriaVIH/sidaobserved July and August 2019published 2023PloS onePubMeddocument of 9 observations

377 people377 (69.7%) of the people living with HIV who refused linkage to treatment eventually accepted treatment using an alternative community treatment method.

NigeriaVIH/sidapublished 2019International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 6 observations

0.8 %Moderately reduced eGFR was observed in 0.8% of the participants in a cohort of 121 HIV-infected children on HAART.

Nigeriakidney disease · VIH/sidapublished 2025African health sciencesPubMeddocument of 7 observations

6 %Previously married females accounted for 6% of the estimated new HIV infections in Lagos state.

NigeriaVIH/sidapublished 2024Journal of the International Association of Providers of AIDS CarePubMeddocument of 7 observations

Glutathione (GSH) and glutathione peroxidase (GPX) were significantly reduced in HIV infection.

NigeriaVIH/sidapublished 2019BMC infectious diseasesPubMeddocument of 7 observations

45.4 %45.4% of respondents reported storing their medicines in a concealed location within their residence.

NigeriaVIH/sidapublished 2025BMC public healthPubMeddocument of 6 observations

13.3 aORAmong HIV-positive participants in the TRUST/RV368 cohort, having 200 or less CD4 cells/mm³ was associated with highly similar anal HPV genotypes at 12 months (adjusted odds ratio 13.3, 95% CI 2.7–65.2).

Nigeriainfection à HPV · VIH/sidapublished 2022Sexually transmitted diseasesPubMeddocument of 13 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.